About us

The Institute of Global Health is the natural evolution of the University of Siena’s tradition in science, infectious diseases, its prevention and treatment, vaccines and public health.

The University of Siena has left its footprint in global health already early in the last century with the pioneering work of its former rector and scientist, Professor Achille Sclavo, who realized the importance of and the need for teaching a broad audience about hygiene principles. His scientific research work at the University of Siena led to the discovery of anthrax antiserum and the establishing of an Vaccine Institute he founded in Siena which was later selected by Albert Sabin as production site for the oral polio vaccine.

This long tradition and diversified activities have established the University of Siena as a center of excellence in bioscience R&D and education. To centralize different educational programs in this area, University has created the Institute for Global Health.

The Institute for Global Health provides specialized courses in select areas of global health, equipping program participants with the practical and professional expertise they need to lead the next generation of scientists, researchers, and health practitioners across the globe.

Contact us

Educational programs

The Institute offers internationally recognized programs delivered by global academic and industry leaders in the areas of basic sciences, political sciences, and public health.

Programs focus on the areas of immunization, infectious diseases, and clinical development, being the only worldwide Master Program awarding an academic degree in this discipline. Over 90% of Institute alumni currently work in global, prominent positions in vaccinology and public health.

Please note that all programs are conducted in English.

Degree Courses

Executive Courses

Contact us

Our team

Founders

Prof. Emanuele Montomoli

Prof. of Public Health
Chairman and founder of Institute for Global Health
President of the Master Programs and Technical Scientific Committee – Clinical Development

Prof. Dr. Sue Ann Costa Clemens

Prof. of Pediatric Infectious Diseases
Director Vaccine Group Oxford-Brazil
Visiting Professor in Global Health at Oxford University, Department of Paediatrics
Head of Institute for Global Health
Director of Master Programs Clinical Development

  Prof. Pietro Lupetti

Full Professor of Comparative Anatomy and Cytology
Founder and PhD Director of Institute for Global Health

International Scientific Board

Emanuele Montomoli
Chairman and founder of Institute for Global Health

Sue Ann Costa Clemens
Founder and Head of Institute for Global Health

Pietro Lupetti
Founder and PhD Director of Institute for Global Health

Fred Zepp
Chairman of the Pediatric department, University of Mainz
Member of the German Vaccine Policy Body – Stiko

Ananda Bandyopadhyay
Senior Program Officer at the Bill & Melinda Gates Foundation

Ingmar Hoerr
Chief Executive Officer, Curevac AG

 

Management

Elena Cellai
Educational Programs Coordinator

Get involved

The Institute for Global Health is grateful to the sponsors and partners who ensure that we can continue to make a lasting impact on global health in the developing world. They share their resources, expertise, and international resources to help support us in our work.


Master in Vaccinology and Pharmaceutical Clinical Development sponsors and partners

GlaxoSmithKline

 

Faculty members – Partner institutions

WHO; EMA; PEI; IVI; CDC; BMGF; ECDC; PATH; GAVI; FIOCRUZ; CHERMID; CHMO; European Community; Sabin Institute; Health Dep. London; Health Dep. Italy; Tropical Lab Antwerp; Federal Agency Belgium; Institute Pasteur; MRC Gambia; Welcome Trust; VisMederi; Brighton Collaboration; Butantan; G-Con; Novartis; Sanofi Pasteur; Roche; GSK; Pfizer; Valneva; Curevac; University of Cincinnati Children’s Hospital; University of Tubingen, Tropical Institute Germany; Institute of Medical Immunology, Faculty of Medicine, University of Brussels; Immunology & Infectiology, University of Mainz Center for Child and Adolescent Medicine, Germany; University, Halifax, Canada; University of Namur, Belgium; London School of Hygiene and Tropical Medicine (LSHTM), Department of Infectious Diseases Epidemiology, London, UK; School of Public Health, Boston University, Boston, USA; London School of Hygiene and Tropical Medicine, London, UK; CPE-Lyon engineer school, Lyon, France

Interested in getting involved? Become a sponsor or a partner and help The Institute for Global Health change the face of medicine in the developing world.

Contact us to be a partner or sponsor

Latest news

Italian Vaccination Reaches Academic Staff

Elena Cellai, Coordinator of Master in Vaccinology and Drug Development has taken the AstraZeneca Oxford vaccine.Special thanks to Prof. Dr. Andrew Pollard, Professor of Paediatric Infection and Immunity at the University of Oxford who leads the COVID-19 vaccine project and is a Faculty member of Master in Vaccinology and Drug Development and Prof. Sue Ann …